191 related articles for article (PubMed ID: 12596012)
1. [Fibrate and statine myopathy].
Finsterer J
Nervenarzt; 2003 Feb; 74(2):115-22. PubMed ID: 12596012
[TBL] [Abstract][Full Text] [Related]
2. Statin-fibrate combination therapy.
Shek A; Ferrill MJ
Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
[TBL] [Abstract][Full Text] [Related]
3. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
4. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
Forcadell-Peris MJ; de Diego-Cabanes C
Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
Graham DJ; Staffa JA; Shatin D; Andrade SE; Schech SD; La Grenade L; Gurwitz JH; Chan KA; Goodman MJ; Platt R
JAMA; 2004 Dec; 292(21):2585-90. PubMed ID: 15572716
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
[TBL] [Abstract][Full Text] [Related]
7. [Myopathies under therapy with lipid-lowering agents].
Köller H; Neuhaus O; Schroeter M; Hartung HP
Nervenarzt; 2005 Feb; 76(2):212-7. PubMed ID: 15609055
[TBL] [Abstract][Full Text] [Related]
8. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
Sparing R; Sellhaus B; Noth J; Block F
Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
[TBL] [Abstract][Full Text] [Related]
9. Focus on fenofibrate.
Brown WV
Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
[No Abstract] [Full Text] [Related]
10. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism.
Kursat S; Alici T; Colak HB
Clin Nephrol; 2005 Nov; 64(5):391-3. PubMed ID: 16312269
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
12. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of statin and fibrate combination therapy in lipid management.
Kota SK; Meher LK; Rao ES; Jammula S; Modi KD
Diabetes Metab Syndr; 2012; 6(3):173-4. PubMed ID: 23158983
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect?
Langford NJ; Kendall MJ
J Clin Pharm Ther; 2001 Dec; 26(6):391-5. PubMed ID: 11722675
[No Abstract] [Full Text] [Related]
15. [Rhabdomyolysis in patients with preexisting myopathy, treated with antilipemic agents].
Franc S; Bruckert E; Giral P; Turpin G
Presse Med; 1997 Dec; 26(38):1855-8. PubMed ID: 9569908
[TBL] [Abstract][Full Text] [Related]
16. [Adverse effects of lipid-lowering medications].
Fukumoto Y; Shimokawa H
Nihon Rinsho; 2007 Oct; 65 Suppl 8():165-72. PubMed ID: 18074533
[No Abstract] [Full Text] [Related]
17. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
19. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.
Lau TK; Leachman DR; Lufschanowski R
Tex Heart Inst J; 2001; 28(2):142-5. PubMed ID: 11453128
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus.
Pariente A; Labat V; Mansiaux Y; Salvo F; Bégaud B; Raschi E; Faillie JL; Létinier L; Bezin J
Drug Saf; 2020 Aug; 43(8):767-774. PubMed ID: 32306223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]